Cargando…

Fasting plus tyrosine kinase inhibitors in cancer

Detalles Bibliográficos
Autores principales: Caffa, Irene, Longo, Valter D., Nencioni, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712327/
https://www.ncbi.nlm.nih.gov/pubmed/26645151
_version_ 1782410047533350912
author Caffa, Irene
Longo, Valter D.
Nencioni, Alessio
author_facet Caffa, Irene
Longo, Valter D.
Nencioni, Alessio
author_sort Caffa, Irene
collection PubMed
description
format Online
Article
Text
id pubmed-4712327
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47123272016-01-25 Fasting plus tyrosine kinase inhibitors in cancer Caffa, Irene Longo, Valter D. Nencioni, Alessio Aging (Albany NY) Editorial Impact Journals LLC 2015-12-06 /pmc/articles/PMC4712327/ /pubmed/26645151 Text en Copyright: © 2015 Caffa et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Caffa, Irene
Longo, Valter D.
Nencioni, Alessio
Fasting plus tyrosine kinase inhibitors in cancer
title Fasting plus tyrosine kinase inhibitors in cancer
title_full Fasting plus tyrosine kinase inhibitors in cancer
title_fullStr Fasting plus tyrosine kinase inhibitors in cancer
title_full_unstemmed Fasting plus tyrosine kinase inhibitors in cancer
title_short Fasting plus tyrosine kinase inhibitors in cancer
title_sort fasting plus tyrosine kinase inhibitors in cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712327/
https://www.ncbi.nlm.nih.gov/pubmed/26645151
work_keys_str_mv AT caffairene fastingplustyrosinekinaseinhibitorsincancer
AT longovalterd fastingplustyrosinekinaseinhibitorsincancer
AT nencionialessio fastingplustyrosinekinaseinhibitorsincancer